Related Experiment Video
Updated: Jan 23, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
MicroRNA-422a functions as a tumor suppressor in non-small cell lung cancer through SULF2-mediated TGF-β/SMAD
Wei-Qiang Li1, Jian-Peng Zhang1, Yan-Yu Wang1
1a Department of Thoracic Surgery , Beijing Luhe Hospital, Capital Medical University , Beijing , P. R. China.
Abstract:
MicroRNAs (miRNAs) have been demonstrated to participate in a variety of human cancers by functioning as post-transcriptional regulators of oncogenes or antioncogenes including non-small cell lung cancer (NSCLC). The aim of the current study was to identify the role of miR-422a in NSCLC via sulfatase 2 (SULF2) to further elucidate the mechanism of NSCLC. Initially, the expression of miR-422a and SULF2 was determined in NSCLC tissues and cells. The role of miR-422a in NSCLC was identified in relation with a miR-422a mimic or inhibitor, siRNA against SULF2 and TGF-β1. The regulatory effects of miR-422a were examined following detection of the related epithelial mesenchymal transition (EMT)-related genes, and the apoptosis-related genes and evaluation of their cellular biological functions. The expression pattern of miR-422a, SULF2, and the TGF-β/SMAD pathway-related genes was detected to elucidate the mechanism by which miR-422a influences the progression of NSCLC. Finally, xenograft tumors in nude mice were observed for tumorigenicity evaluation purposes. Our results showed that miR-422a was poorly expressed while SULF2 was highly expressed in NSCLC. Dual luciferase reporter gene assay further verified that miR-422a targeted SULF2. Altogether, this study demonstrated that miR-422a downregulated SULF2 to inhibit the TGF-β/SMAD pathway. NSCLC cell proliferation, migration, invasion, colony formation, EMT and tumorigenesis were all inhibited while apoptosis was promoted upon restoration of miR-422a or silencing of SULF2. However, the activation of the TGF-β/SMAD pathway was determined to reverse the tumor-suppressive effects of si-SULF2. miR-422a restoration, which ultimately inhibited the progression of NSCLC by suppressing the TGF-β/SMAD pathway via SULF2.
Insights
MicroRNA-422a (miR-422a) inhibits non-small cell lung cancer (NSCLC) by downregulating sulfatase 2 (SULF2). This suppression blocks the TGF-β/SMAD pathway, reducing tumor growth and promoting apoptosis in NSCLC.
Area of Science:
- Oncology
- Molecular Biology
- Gene Regulation
Background:
- MicroRNAs (miRNAs) regulate gene expression and are implicated in various cancers, including non-small cell lung cancer (NSCLC).
- The specific role of miR-422a and its regulatory targets in NSCLC progression require further elucidation.
Purpose of the Study:
- To investigate the role of miR-422a in NSCLC pathogenesis.
- To identify sulfatase 2 (SULF2) as a direct target of miR-422a.
- To elucidate the mechanism by which miR-422a influences NSCLC progression via the TGF-β/SMAD pathway.
Main Methods:
- Expression analysis of miR-422a and SULF2 in NSCLC tissues and cells.
- In vitro studies using miR-422a mimics/inhibitors and SULF2 siRNA.
- Dual luciferase reporter gene assays to confirm direct targeting.
- Assessment of epithelial-mesenchymal transition (EMT) and apoptosis-related genes.
- In vivo tumorigenicity evaluation in xenograft mouse models.
Main Results:
- miR-422a was significantly downregulated, while SULF2 was upregulated in NSCLC.
- miR-422a directly targets and downregulates SULF2.
- miR-422a/SULF2 axis suppressed NSCLC cell proliferation, migration, invasion, colony formation, and EMT.
- miR-422a/SULF2 axis promoted apoptosis in NSCLC cells.
- Silencing SULF2 or restoring miR-422a inhibited tumor growth, while TGF-β/SMAD pathway activation reversed these effects.
Conclusions:
- miR-422a functions as a tumor suppressor in NSCLC by targeting SULF2.
- The miR-422a/SULF2 interaction inhibits the TGF-β/SMAD pathway, thereby suppressing NSCLC progression.
- Restoring miR-422a or inhibiting SULF2 represents a potential therapeutic strategy for NSCLC.
More Related Videos
Related Concept Videos
TGF - β Signaling Pathway
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
MicroRNAs
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...

